Tecfidera hosrse banner
Tecfidera hosrse banner

Formulary Coverage and Copay Program for Eligible Patients

Leading coverage can get your patients off to a quick start

TECFIDERA Formulary Coverage
TECFIDERA Formulary Coverage

87% First-Line Coverage1*

TECFIDERA is covered as a first-line relapsing MS therapy (unrestricted access) for 87% of commercial patients as of March 2019.

*Coverage may vary, and there is no guarantee of coverage.



TECFIDERA Copay Program
TECFIDERA Copay Program

Biogen Copay Program

The Biogen Copay Program may lower medication cost to as low as $0 for eligible patients with commercial insurance.